Author

Zeying Feng

h-index 3 View on Semantic Scholar

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Plasma Angiotensin-Converting Enzyme as a Prioritized Candidate Target for Alzheimer's Disease: Evidence From Proteome-Wide Mendelian Randomization and a Large Prospective Cohort Study.

Genetic analyses prioritized angiotensin-converting enzyme as a candidate target, and a conventional observational analysis in a large prospective cohort provided supportive evidence that regular angiotensin-converting enzyme inhibitor use was associated with a higher AD risk.

Pei-Guan Huang, Hai-Bo Tang, Ze-Ying Feng et al. · Journal of the American Hear... · 0 citations

Open access Aug 2026

Intelligent Framework for Adverse Drug Event Identification Using Large Language Models and Retrieval-Augmented Generation: Development and Evaluation Study

Synergizing a curated domain-specific knowledge base with LLMs via a RAG architecture is an effective strategy for accurately identifying ADEs in unstructured Chinese clinical notes, providing a foundational open-source benchmark and a robust technical framework to advance pharmacovigilance, drug safety research, and c...

Junlong Ma, Xue-Hong Wu, Zeying Feng et al. · Journal of Medical Internet... · 0 citations